Food, Drugs, Healthcare, Life Sciences

The FDA has sent reminder letters to over 2,200 drug, biologic, and medical device companies regarding potential failures to publish required clinical trial results on ClinicalTrials.gov.

On April 8, 2026, the Department of Health and Human Services’ Office for Civil Rights (OCR) released an educational video, Risk Management Under the HIPAA Security Rule, detailing the risk management requirements under HIPAA as well as findings and conclusions from OCR’s investigations. While framed as an educational outreach video, it sends a clear enforcement message: risk management is mandatory, ongoing, and increasingly scrutinized by OCR.

How can healthcare organizations build defensible governance frameworks for physician compensation arrangements while navigating the complex regulatory landscape of federal laws? This podcast episode explores the intersection of compliance requirements and strategic goals, examining the critical role of dual-committee oversight and fair market value standards in an era of heightened enforcement.